The U.S. House of Representatives generated buzz in November 2020 when it passed a bill aimed at removing a loophole in the Orphan Drug Act. Although the bill did not make it far in the Senate, the bipartisan legislative push...more
In an effort to provide opportunities for more junior practitioners to gain experience in proceedings before the PTAB, the USPTO earlier this year established the Legal Experience and Advancement Program (LEAP). To encourage...more
From inventors and trade groups to legal scholars and judges, many have expressed frustrations with the current state of patent eligibility in the United States. In particular, the lack of clarity in assessing patent...more
The US Patent and Trademark Office (USPTO) implemented a new pilot program on March 15, 2019 concerning motion-to-amend practice in America Invents Act (AIA) trials, including post-grant review (PGR), inter partes review...more